Quarterly Result9 May 2025, 12:13 pm
Hester Biosciences Reports 17% Profit Growth in FY25, Declares 70% Dividend
AI Summary
Hester Biosciences Ltd. has reported a 17% growth in profit for the financial year 2024-25 and has declared a dividend of 70%. The company's standalone and consolidated financial results for the quarter and year ended 31 March 2025 have been approved in the recent Board Meeting. The company has also appointed Shah & Shah Associates, Company Secretaries, Ahmedabad as the Secretarial Auditors for a period of five consecutive years from FY 2025-26 to FY 2029-30.
Key Highlights
- Hester Biosciences reports a 17% growth in profit for FY25
- The company declares a dividend of 70% for the financial year 2024-25
- Standalone and consolidated financial results for Q4 & FY25 approved
- Shah & Shah Associates appointed as Secretarial Auditors for five years